Extracorporeal Support
Hyperoxia Is Associated With Poor Outcomes in
Pediatric Cardiac Patients Supported on Venoarterial
Extracorporeal Membrane Oxygenation*
Nathaniel R. Sznycer-Taub, MD1; Ray Lowery, BS1; Sunkyung Yu, MS1; Sonal T. Owens, MD1;
Jennifer C. Hirsch-Romano, MD, MS1,2; Gabe E. Owens, MD, PhD1
Objectives: Patients who require venoarterial extracorporeal mem- controlling for the variables listed above, a mean Pao greater
2
brane oxygenation because of cardiac failure frequently have than 193 mm Hg remained an independent risk factor for mortality
supranormal blood oxygen tensions (hyperoxia). Recent stud- (p = 0.03). In addition, a mean Pao greater than 193 mm Hg was
2
ies have suggested worse outcomes in patients with hyperoxia associated with the need for renal dialysis (p = 0.02) but not with
after resuscitation from cardiac or respiratory arrests, presumably neurologic injury (p = 0.41) during the hospitalization.
because of oxidative stress. There are limited data regarding the Conclusions: In infants with congenital heart disease who are
effect of hyperoxia on outcomes in pediatric patients on venoarte- placed on venoarterial extracorporeal membrane oxygenation
rial extracorporeal membrane oxygenation. postoperatively, hyperoxia (defined as a mean Pao > 193 mm Hg
2
Design: Retrospective chart review. in the first 48 hr of extracorporeal membrane oxygenation) was an
Setting: Pediatric cardiothoracic ICU. independent risk factor for 30-day mortality after surgery. Future
Patients: Cardiac surgery patients less than 1 year old requiring studies are needed to delineate the causative or associative role
venoarterial extracorporeal membrane oxygenation in the postop- of hyperoxia with outcomes, especially in children with baseline
cyanosis who may be more susceptible to the effects of oxidative
erative period from 2007 to 2013.
stress. (Pediatr Crit Care Med 2016; 17:350–358)
Measurements and Main Results: In 93 infants (median time on extra-
Key Words: extracorporeal membrane oxygenation; heart defects,
corporeal membrane oxygenation, 5 d), mortality at 30 days post
congenital; hyperoxia; thoracic surgery
surgery (primary outcome) was 38%. Using a receiver operating
characteristic curve, a mean Pao of 193 mm Hg in the first 48 hours
2
of extracorporeal membrane oxygenation was determined to have
good discriminatory ability with regard to 30-day mortality. Univariate T
he use of mechanical circulatory support after congenital
analysis identified a mean Pao
2
greater than 193 mm Hg (p = 0.001),
heart surgery in the form of extracorporeal membrane
longer cardiopulmonary bypass times (p = 0.09), longer duration
oxygenation (ECMO) is estimated to occur after 3–5%
of extracorporeal membrane oxygenation (p < 0.0001), and higher
of all surgeries, and the overall mortality for patients is approxi-
extracorporeal membrane oxygenation pump flows (p = 0.052) as mately 40–65% (1–3). Common indications for the use of ECMO
possible risk factors for 30-day mortality. In multivariable analysis postoperatively include failure to wean from cardiopulmonary
bypass due to myocardial dysfunction, low cardiac output state,
*See also p. 371. cardiac or respiratory arrest, pulmonary hypertension, or shunt
1Division of Pediatric Cardiology, Department of Pediatrics and occlusion. Postoperative patients are most often supported with
Communicable Disease, University of Michigan, Ann Arbor, MI. venoarterial ECMO (VA-ECMO) where deoxygenated blood is
2Section of Pediatric Cardiac Surgery, Department of Cardiac Surgery, removed from the venous side of the circulation and oxygenated
University of Michigan, Ann Arbor, MI.
via the oxygenator resulting in highly oxygenated blood (Pao,
Dr. Sznycer-Taub received support for travel from the University of Michi- 2
> 400 mm Hg) returned directly to the arterial side of the cir-
gan (travel funds to present abstract) and received grant support from
the University of Michigan Internal Funding. The remaining authors have culation. The myocardium (via the coronary arteries) and other
disclosed that they do not have any potential conflicts of interest. organs such as the brain, lungs, kidneys, and gastrointestinal tract
Address requests for reprints to: Nathaniel Sznycer-Taub, MD, University are, thus, exposed to these high levels of oxygen (hyperoxia).
of Michigan Congenital Heart Center, C.S. Mott Children’s Hospital, 1540
Potential negative effects of hyperoxia include the genera-
East Hospital Drive, Ann Arbor, MI. E-mail: nsznycer@med.umich.edu
tion of reactive oxygen species that leads to increased oxidative
Copyright © 2016 by the Society of Critical Care Medicine and the World
Federation of Pediatric Intensive and Critical Care Societies stress and cellular damage as well as activation of neutrophils
DOI: 10.1097/PCC.0000000000000655 and platelets leading to an exaggerated inflammatory and
350 www.pccmjournal.org April 2016 • Volume 17 • Number 4
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited Unauthorized reproduction of this article is prohibited
Extracorporeal Support
thrombotic cascade (4). The effect of hyperoxia has been exten- with systemic to pulmonary artery shunts, it is standard prac-
sively studied in other clinical situations such as after resuscita- tice to leave the shunt patent in most cases unless there are sig-
tion from cardiac arrest (5–10) or perinatal asphyxia (11, 12) nificant issues with an elevated ratio of pulmonary to systemic
and after myocardial infarctions (13). Furthermore, in cyanotic blood flow.
pediatric patients with congenital heart disease, decreasing the Descriptive statistics are reported as frequency with per-
amount of oxygen in the cardiopulmonary bypass circuit to centage for categorical variables and median with interquartile
match the patient’s preoperative Pao has been shown to lead range (IQR) for continuous variables. The maximum, median,
2
less end-organ damage, inflammation, and oxidative stress and mean Pao values in the first 48 hours on ECMO were cal-
2
compared with exposing the patients to Pao values between culated for each patient. Using receiver operating characteris-
2
150 and 200 mm Hg (14, 15). tic (ROC) curves, the area under the curves (AUCs) of each of
Given the concern that hyperoxia may be harmful to patients three Pao metrics were compared to determine the most pre-
2
while on ECMO and the lack of data within this area, we aimed dictive metric of Pao for the primary outcome. The optimal
2
to examine the potential effect of hyperoxia on infants who cutoff of the selected metric of Pao in the first 48 hours was
2
were placed onto VA-ECMO after cardiac surgery. then determined as the best combination of sensitivity and
specificity for significant discrimination of the primary out-
come from the ROC curve. To ascertain the predictive ability
MATERIALS AND METHODS
of the optimal cutoff, sensitivity, specificity, positive predic-
A retrospective chart review of all infants was performed
tive value (PPV), and negative predictive value (NPV) were
(< 1 yr old) who were placed onto VA-ECMO after surgery
calculated for the overall cohort and for subgroups of neo-
for congenital heart disease from July 1, 2007, to June 30,
nates and patients who underwent a Norwood procedure with
2013, at the University of Michigan. After study approval from
systemic to pulmonary artery shunt placement. Patient and
the Institutional Review Board, the internal ECMO registry
clinical characteristics were compared between patients based
was reviewed and patients who met the inclusion criteria
on the primary outcome, using chi-square test or Fisher exact
were identified. Patients who were on ECMO preoperatively,
test, as appropriate, for the categorical variables and Wilcoxon
patients who were placed on ECMO greater than 30 days post-
signed rank test for continuous variables. Variables associated
operatively, and patients who were supported on ECMO less
with 30-day mortality in the univariate analysis (p < 0.1) were
than 24 hours were excluded from the analysis. Electronic
included in the multivariable model to evaluate independent
charts and the internal congenital heart surgery database
associations of possible risk factors with 30-day mortality.
were reviewed, and demographic and clinical data were col-
Unadjusted and adjusted odds ratios and their 95% CIs were
lected. Surgical procedures were stratified based on complex-
estimated using logistic regression. Finally, similar univari-
ity per the Society of Thoracic Surgeons and the European
Association for Cardio-Thoracic Surgery (STAT) Mortality
ate comparisons between patients with mean Pao
2
values in
the first 48 hours above and below the optimal cutoff were
Categories (16). If available, the first arterial blood gas prior
made in patient and clinical characteristics and the secondary
to cannulation for ECMO was collected (if a patient was can-
outcomes. All analyses were performed using SAS, version 9.4
nulated in the operating room, then the blood gas prior to
(SAS Institute, Cary, NC). p value less than 0.05 was consid-
surgery was included). In addition, all arterial blood gases in
ered statistically significant.
the first 48 hours after cannulation for ECMO were also col-
lected. If individual patients were placed on ECMO multiple
times in their life or hospitalization, only data from the first RESuLTS
ECMO cannulation were collected. A total of 93 patients were included in the study. Patient char-
The primary outcome was 30-day mortality after the ini- acteristics are presented in Table 1. The median age at the time
tial surgery. Secondary outcomes included ICU length of stay, of surgery was 7 days, and 75% were neonates. Eighty-five
hospital length of stay, in-hospital mortality, need for dialysis, percent of the patients had STAT scores of 4 or 5, and most
and neurologic injury during the hospitalization (defined as (88%) had preoperative cyanotic heart disease. Forty-five per-
seizure, stroke, or intracranial hemorrhage). If available, trans- cent of patients were cannulated on to ECMO in the operating
thoracic echocardiograms performed within the first 48 hours room, and 66% of patients were placed on to ECMO less than
of cannulation on to ECMO were reviewed by an independent 24 hours after surgery. The median length of time on ECMO
physician specialized in echocardiography (S.T.O.) to evaluate was 5 days. The most common indication for ECMO was fail-
the amount of ventricular dysfunction. ure to wean from cardiopulmonary bypass in the operating
With regard to ECMO support, from July 2007 to June room (47%), and the majority of patients (86%) were cannu-
2010, silicone oxygenators from Medtronic (Minneapolis, lated via the chest. Ten patients had the sweep gas intentionally
MN) were used. Starting in July 2010, the ECMO circuits used blended to achieve lower arterial oxygen tensions during the
Quadrox oxygenators from Maquet (Wayne, NJ). From July study period. The median of the lowest Fio of the sweep gas
2
2007 to March 2010, ECMO flows were provided by roller in the first 48 hours in these patients was 40% (IQR, 32.5–40).
pumps. Starting in April 2010, ECMO flow was provided by There was 38% mortality at 30 days after surgery and 49% in-
centrifugal pumps. Ventilator settings were placed at “rest set- hospital mortality. The median ICU length of stay was 22 days
tings” to avoid barotrauma with an Fio of 21%. In patients (IQR, 16–44). Thirty-eight percent of patients required renal
2
Pediatric Critical Care Medicine www.pccmjournal.org 351
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited
Sznycer-Taub et al
TAbLE 1. Patient and Clinical Characteristics Stratified by Mortality at 30 Days
After Surgery
Mortality at 30 d After Surgery
All Yes No
Characteristics (n = 93) (n = 35) (n = 58) p
Male sex 54 (58.1) 21 (60.0) 33 (56.9) 0.77
Caucasian race 56 (60.2) 22 (62.9) 34 (58.6) 0.28
Premature (gestational age < 37 wk) 13 (14.0) 5 (14.3) 8 (13.8) 1.00
Genetic syndrome(s) 7 (7.5) 1 (2.9) 6 (10.3) 0.25
Neurologic injury during hospitalization 9 (9.7) 3 (8.6) 6 (10.3) 1.00
Age at surgery, d 7 (5–20) 9 (5–35) 6.5 (4–14) 0.14
Neonate (< 30 d) 70 (75.3) 24 (68.6) 46 (79.3) 0.24
Weight at surgery, kg 3.3 (2.9–3.8) 3.5 (2.9–4.0) 3.3 (2.9–3.7) 0.74
Preoperative cyanosis 82 (88.2) 32 (91.4) 50 (86.2) 0.53
Society of thoracic surgeons–European association for cardiothoracic surgery congenital heart surgery database category
1–3 14 (15.1) 5 (14.3) 9 (15.5) 0.87
4 or 5 79 (84.9) 30 (85.7) 49 (84.5)
Norwood procedure 35 (37.6) 13 (37.1) 22 (37.9) 0.94
Cardiopulmonary bypass time, min 156 (101–216) 172 (101–263) 138 (88–197) 0.09
Aortic cross-clamp time, min 45.5 (33.5–83.5) 47 (33–97) 45 (34–79) 0.71
Circulatory arrest time, min (n = 55) 38 (31–45) 38.5 (30.5–46) 37 (31–45) 0.94
Sweep gas blended 10 (10.8) 2 (5.7) 8 (13.8) 0.31
Duration on ECMO, d 5.3 (3.0–7.0) 7.4 (3.7–11.2) 4.2 (2.9–5.9) 0.001
≥ 7 24 (24.5) 18 (51.4) 6 (10.3) < 0.0001
< 7 74 (75.5) 17 (48.6) 52 (89.7)
Indication for cannulation
Low cardiac output/poor perfusion 16 (17.2) 7 (20.0) 9 (15.5) Not
applicable
Failure to wean from cardiopulmonary bypass 44 (47.3) 18 (51.4) 26 (44.8)
Pulmonary hypertension 2 (2.2) 0 (0.0) 2 (3.4)
Combined cardiac and respiratory failure 26 (28.0) 9 (25.7) 17 (29.3)
Respiratory failure/hypoxia (not pulmonary 2 (2.2) 0 (0.0) 2 (3.4)
hypertension)
Shunt occlusion 3 (3.2) 1 (2.9) 2 (3.4)
Cannulation during extracorporeal cardiopulmonary 28 (30.1) 10 (28.6) 18 (31.0) 0.8
resuscitation
Location of cannulation
Operating room 42 (45.2) 17 (48.6) 25 (43.1) 0.61
ICU 51 (54.8) 18 (51.4) 33 (56.9)
Cannulation site
Chest 80 (86.0) 30 (85.7) 50 (86.2) 1.00
Neck 13 (14.0) 5 (14.3) 8 (13.8)
(Continued)
352 www.pccmjournal.org April 2016 • Volume 17 • Number 4
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited Unauthorized reproduction of this article is prohibited
Extracorporeal Support
TAbLE 1. (Continued). Patient and Clinical Characteristics Stratified by Mortality at
30 Days After Surgery
Mortality at 30 d After Surgery
All Yes No
Characteristics (n = 93) (n = 35) (n = 58) p
Additional ECMO cannulation 11 (11.8) 1 (2.9) 10 (17.2) 0.048
Pump flows in the first 48 hr, cc/kg
Minimum 82.7 (66.1–100) 85.0 (66.7–117) 82.6 (65.2–93.1) 0.17
≥ 120 12 (12.9) 8 (22.9) 4 (6.9) 0.052
< 120 80 (86.0) 27 (77.1) 53 (91.4)
Mean Pao (during first 48 hr), mm Hg
2
> 193 73 (78.5) 34 (97.1) 39 (67.2) 0.001
< 193 20 (21.5) 1 (2.9) 19 (32.8)
ECMO = extracorporeal membrane oxygenation.
dialysis, and 42% had evidence of neurologic injury (stroke, 0.60–0.84) in neonates and 0.71 (95% CI, 0.54–0.89) in patients
seizures, or intracranial hemorrhage). who underwent a Norwood procedure with a systemic to pul-
Arterial blood gases prior to cannulation for ECMO were monary artery shunt. In neonates, a mean Pao of 193 mm Hg
2
available in 83 patients. The median pH was 7.35 (IQR, 7.19– had a sensitivity of 100%, a specificity of 37%, and an NPV of
7.39), Pao was 40.0 mm Hg (IQR, 32.8–62.2), and lactate was 100%, whereas in patients who underwent a Norwood proce-
2
3.5 mmol/L (IQR, 1.3–13.0). dure, the cutoff had a sensitivity of 100%, a specificity of 50%,
The median number of arterial blood gas measurements in and an NPV of 100%. The distribution of the mean Pao in the
2
the first 48 hours of ECMO was 15 (range, 4–28) across the entire first 48 hours with regard to the primary outcome is shown in
cohort. Using ROC curves, the mean Pao in the first 48 hours Figure 1 for the overall cohort and the subgroups.
2
was the most predictive metric for mortality 30 days after surgery In univariate analysis, factors significantly associated with
(AUC, 0.65; 95% CI, 0.54–0.76) compared with other Pao met- mortality 30 days after surgery included longer duration on
2
rics (AUC, 0.58 and 0.61 in maximum and median Pao, respec- ECMO (p < 0.0001) and a mean Pao in the first 48 hours of
2 2
tively). A mean Pao of 193 mm Hg in the first 48 hours showed a greater than 193 mm Hg (p = 0.001) (Table 1). With exclusion
2
good discrimination between the outcomes, with a sensitivity of of the patients who had the sweep gas blended, a mean Pao
2
97%, specificity of 33%, PPV of 47%, and NPV of 95%. Seventy- greater than 193 mm Hg was still significantly associated with
three patients (78%) in the cohort had a mean Pao greater than increased 30-day mortality (p = 0.001). Longer cardiopulmo-
2
193 mm Hg in the first 48 hours of ECMO. nary bypass times and higher minimum ECMO pump flows in
The mean Pao in the first 48 hours also demonstrated good the first 48 hours trended toward a significant association with
2
discriminatory abilities in the subgroups: AUC, 0.72 (95% CI, 30-day mortality (p = 0.09 and 0.052, respectively).
Figure 1. Distribution of mean Pao in the first 48 hr of extracorporeal membrane oxygenation with regard to 30-d mortality in infants (age < 1 yr) (A),
2
neonates (age < 30 d) (b), and neonates who underwent a Norwood procedure with a systemic to pulmonary artery shunt (C).
Pediatric Critical Care Medicine www.pccmjournal.org 353
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited
Sznycer-Taub et al
In multivariable analysis, a mean Pao in the first 48 hours that were placed onto ECMO outside of the postoperative set-
2
greater than 193 mm Hg and longer duration on ECMO ting to limit confounders given that cardiopulmonary bypass
remained independently associated with 30-day mortality in infants is known to cause a significant systemic inflamma-
(Table 2). tory response (17).
The entire patient cohort was stratified by a mean Pao Overall, the majority of the patients in the cohort were neo-
2
of 193 mm Hg in the first 48 hours, and patient and clinical nates, and approximately a third of the patients underwent a
characteristics were compared (Table 3). Factors significantly Norwood arch reconstruction with a systemic to pulmonary
associated with a mean Pao in the first 48 hours greater artery shunt. These factors in addition to the fact that the
2
than 193 mm Hg included longer cardiopulmonary bypass majority of patients had a STAT mortality score of 4 or 5 indi-
(p = 0.02) and aortic cross-clamp times (p = 0.01), longer dura- cate that the cohort, as expected, is a high-risk patient group.
tion on ECMO (p < 0.0001), and higher ECMO pump flows. Longer duration on ECMO was found to be a risk factor for
Ventricular function (normal or mildly depressed vs mod- mortality after congenital heart surgery, which is similar to
erately or severely depressed) on an echocardiogram within previously published data (18, 19).
48 hours of cannulation was not associated with mean Pao There has been a considerable amount of interest recently
2
values (p = 0.19). in the potential effects of hyperoxia during and after periods
In terms of end-organ disease, the prevalence of renal dialy- of tissue ischemia. The introduction of high amounts of oxy-
sis (p = 0.02) but not neurologic injury (p = 0.41) was sig- gen to previously ischemic tissues leads to the generation of
nificantly higher in the patients with a mean Pao greater than
reactive oxygen species and activation of inflammatory path-
2
193 mm Hg (Table 3).
ways via cytokines (20). Reactive oxygen species lead to lipid
peroxidation and protein changes, which cause cell injury via
DISCuSSION direct damage or apoptosis (21). The effect may be even more
In infants with congenital heart disease who are placed on VA- pronounced in pediatric patients as neonates, and infants are
ECMO in the postoperative setting, hyperoxia (defined in this known to have immature antioxidant defenses and thus may be
study as a mean Pao > 193 mm Hg in the first 48 hr of ECMO) more susceptible to the reactive oxygen species (22). In addi-
2
was an independent risk factor for 30-day mortality. To our tion, the reactive oxygen species can activate neutrophils and
knowledge, this is the first study to investigate the potential platelets leading to an exaggerated inflammatory and throm-
effects of hyperoxia on patients supported on ECMO. In this botic response (4), which could theoretically increase the risk
study, we aimed to choose a narrow subset of patients given of complications on ECMO.
the vast heterogeneity of clinical and surgical characteristics of A review of the current literature indicates that across a
patients who are placed on ECMO and therefore the multiple wide variety of clinical scenarios and situations, the effect of
confounders that could contribute to outcomes. The patients hyperoxia is unclear. After resuscitation from cardiac arrests,
in this cohort are all infants who had cardiac surgery requiring hyperoxia in adults has been associated with increased risk of
cardiopulmonary bypass for repair of congenital heart lesions. mortality (9, 23). On the other hand, supplemental oxygen
We excluded patients without congenital heart disease or those therapy after myocardial infarctions was not shown to have
TAbLE 2. Factors Associated With Mortality 30 Days After Surgery
unadjusted Adjusted
Characteristics OR 95% CI pa AOR 95% CI pb
Cardiopulmonary bypass time 1.004 1.00–1.01 0.08 1.00 0.994–1.01 0.88
Duration on extracorporeal membrane oxygenation, d
≥ 7 9.18 3.29–28.9 < 0.0001 5.3 1.61–17.4 0.01
< 7 Ref Ref
Minimum pump flows in the first 48 hr, cc/kg
≥ 120 3.86 0.94–19.2 0.052 2.11 0.47–9.38 0.33
< 120 Ref Ref
Mean Pao during first 48 hr, mm Hg
2
> 193 16.6 3.17–305 0.001 9.79 1.18–81.0 0.03
< 193 Ref Ref
OR = odds ratio (unadjusted), AOR = adjusted odds ratio, Ref = reference category.
ap value from univariate logistic regression.
bp value from multivariable logistic regression.
354 www.pccmjournal.org April 2016 • Volume 17 • Number 4
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited Unauthorized reproduction of this article is prohibited
Extracorporeal Support
TAbLE 3. Patient Characteristics and Secondary Outcomes by Mean Pao in the First
2
48 Hours
Mean Pao in the First 48 hr
2
> 193 mm Hg < 193 mm Hg
Characteristics (n = 73) (n = 20) p
Age at surgery, d 8 (5–31) 5.5 (3–8) 0.09
Neonate (< 30 d) 53 (72.6) 17 (85.0) 0.38
Weight at surgery, kg 3.3 (2.9–3.8) 3.4 (3.2–3.7) 0.65
Preoperative cyanosis 64 (87.7) 18 (90.0) 1.00
Society of thoracic surgeons–European association for cardiothoracic surgery congenital heart surgery database category
1–3 13 (17.8) 1 (5.0) 0.29
4 or 5 60 (82.2) 19 (95.0)
Norwood procedure 24 (32.9) 11 (55.0) 0.07
Cardiopulmonary bypass time, min 159 (107–236) 128 (81–179) 0.02
Aortic cross-clamp time, min 49.5 (35–99.5) 38 (16–46.5) 0.01
Circulatory arrest time, min (n = 55) 38 (28–45) 38 (34–45) 0.84
Sweep gas blended 3 (4.1) 7 (35.0) 0.001
Duration on ECMO, d 6.1 (3.8–9.1) 2.9 (2.3–3.6) < 0.0001
≥ 7 24 (32.9) 0 (0.0) 0.003
< 7 49 (67.1) 20 (100.0)
Indication for cannulation
Low cardiac output/poor perfusion 14 (19.2) 2 (10.0) Not
applicable
Failure to wean from cardiopulmonary bypass 37 (50.7) 7 (35.0)
Pulmonary hypertension 1 (1.4) 1 (5.0)
Combined cardiac and respiratory failure 20 (27.4) 6 (30.0)
Respiratory failure/hypoxia (not pulmonary 0 (0.0) 2 (10.0)
hypertension)
Shunt occlusion 1 (1.4) 2 (10.0)
Cannulation during extracorporeal 21 (28.8) 7 (35.0) 0.59
cardiopulmonary resuscitation
Location of cannulation
Operating room 36 (49.3) 6 (30.0) 0.12
ICU 37 (50.7) 14 (70.0)
Cannulation site
Chest 63 (86.3) 17 (85.0) 1.00
Neck 10 (13.7) 3 (15.0)
Additional ECMO cannulation 8 (11.0) 3 (15.0) 0.7
Pump flows in the first 48 hr, cc/kg
Minimum 86.6 (71.7–103) 64.8 (56.2–82.6) 0.003
≥ 120 11 (15.1) 1 (5.0) 0.45
< 120 61 (83.6) 19 (95.0)
(Continued)
Pediatric Critical Care Medicine www.pccmjournal.org 355
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited
Sznycer-Taub et al
TAbLE 3. (Continued). Patient Characteristics and Secondary Outcomes by Mean Pao in
2
the First 48 Hours
Mean Pao in the First 48 hr
2
> 193 mm Hg < 193 mm Hg
Characteristics (n = 73) (n = 20) p
Need for renal dialysis 32 (43.8) 3 (15.0) 0.02
Neurologic injury during hospitalization 29 (39.7) 10 (50.0) 0.41
Seizure 21 (28.8) 2 (10.0) 0.14
Stroke 9 (12.3) 4 (20.0) 0.47
Intracranial hemorrhage 12 (16.4) 6 (30.0) 0.21
ICU length of stay, d 21 (14–42) 28.5 (20–52) 0.08
Hospital length of stay, d 28 (18–63) 48 (31–64) 0.09
In-hospital mortality 41 (56.2) 5 (25.0) 0.01
ECMO = extracorporeal membrane oxygenation.
any clinically apparent effect (13). In pediatric patients, the greater than 193 mm Hg was associated with increased 30-day
data are mixed as hyperoxia has been shown to be both associ- mortality.
ated (6, 8) and not associated with increased risk of mortality There are other factors that can contribute to changes in the
(5, 7) after cardiac arrests. In neonates with asphyxia, hyper- arterial oxygen tension in patients supported on VA-ECMO.
oxia was associated with increased mortality and risk of brain Rarely, mechanical issues with the oxygenator can lower the
injury (11, 12). Finally, in children undergoing cardiac surgery Pao values. In addition, oxygen tension of blood ejected from
2
to repair congenital heart lesions (which often necessitates a the systemic ventricle and the ratio of mixing of blood from
period of tissue hypoxia during cardioplegic arrest of the heart the systemic ventricle and the arterial ECMO cannula can
or during deep hypothermic circulatory arrest), patients on affect the overall arterial (and hence end organ) oxygen ten-
cardiopulmonary bypass who were exposed to hyperoxia had sion. Pulmonary venous desaturation from lung disease (com-
increased evidence of end-organ damage, oxidative stress, and mon in postoperative patients on ECMO) or mixing at the
inflammation (14, 15). atrial and/or ventricular levels may cause relatively decreased
There are also limited data to suggest that hyperoxia may oxygen tension of the blood ejected from the systemic ventricle
be beneficial in certain situations. In animal models, hyperoxia in relation to blood returning from the arterial cannula. Most
after cardiac arrest was associated with improved myocardial patients in our study were cannulated for ECMO in the post-
function (24) and also shown to be neuroprotective in cere- operative setting due to low cardiac output or failure to wean
bral ischemia (25). Early data in human subjects showed that from cardiopulmonary bypass and therefore likely had some
selective perfusion of coronary arteries with a hyperoxemic element of ventricular dysfunction. One could hypothesize
solution resulted in improved left ventricular function (26); that a patient with better ventricular function would, there-
however, subsequent studies have failed to show any signifi- fore, eject more blood that has a relatively lower oxygen ten-
cant effect (27). sion, thus mixing with the highly oxygenated blood from the
As a result of the data suggesting the negative effects of aortic cannula and leading to overall decreased oxygen tension.
hyperoxia, there has been considerable interest in modifying However, in this study, when we analyzed available echocar-
oxygen exposure to patients. Current resuscitation guidelines diograms in the first 48 hours after ECMO cannulation, worse
in pediatrics and adults recommend titration of supplemental ventricular function was not found to be significantly associ-
oxygen after a cardiac arrest (28, 29). In patients supported on ated with a higher mean Pao.
2
VA-ECMO, clinicians can titrate (or blend) the oxygen con- Another important factor is ECMO pump flow as higher
tent of the sweep gas of the oxygenator to achieve more “physi- flows would presumably decrease the amount of pulmonary
ologic” Pao levels. However, the practice is not universal. Our venous return and therefore decrease preload to the systemic
2
group conducted an informal survey of other pediatric cardiac ventricle. This could lead to decreased ejection of the “deoxy-
ICUs and found that two-thirds of units are titrating to goal genated” blood into the aorta. Interestingly, when adjusting for
Pao levels, whereas the other third maintain elevated Pao lev- ECMO pump flow and other factors, a mean Pao greater than
2 2 2
els. In our study, only a minority (11%) of patients had the 193 mm Hg was still associated with increased risk of 30-day
sweep gas blended (likely at supervising physician discretion) mortality, suggesting that the association is not dependent
at the end of the time period of the chart review. With both on the requirement for increased ECMO support. In addi-
inclusion and exclusion of this group of patients, a mean Pao tion, although we observed that higher ECMO pump flows
2
356 www.pccmjournal.org April 2016 • Volume 17 • Number 4
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited Unauthorized reproduction of this article is prohibited
Extracorporeal Support
trended toward a significant association with mortality in the ECMO but also that a change of practice in management of
univariate analysis and patients with a higher average Pao had these patients in many centers may be prudent. In addition,
2
significantly higher pump flows, higher ECMO pumps flows we would propose that hyperoxia on ECMO may be used
were not an independent risk factor for 30-day mortality in as a tool for clinicians to prognosticate potential ventricular
the multivariable analysis. Thus, there is some suggestion from recovery and the likelihood of survival after ECMO decannu-
this study that elevated Pao levels may have a causative (due to lation, which may influence decisions regarding further inter-
2
reactive oxygen species or other mechanisms) effect on clini- vention or institution of long-term mechanical support (i.e.,
cal outcome versus simply being associative due to improved ventricular assist devices).
clinical parameters. Although further studies are required to
delineate these phenomena, the results of this study showed
REFERENCES
that hyperoxia has a very high sensitivity and NPV for mortal-
1. Aharon AS, Drinkwater DC Jr, Churchwell KB, et al: Extracorporeal
ity. As shown in the results, there were very few patients who membrane oxygenation in children after repair of congenital cardiac
did not survive to 30 days after surgery with a mean Pao less lesions. Ann Thorac Surg 2001; 72:2095–2101
2 2. Mascio CE, Austin EH 3rd, Jacobs JP, et al: Perioperative mechanical
than 193 mm Hg.
circulatory support in children: An analysis of the Society of Thoracic
Secondary outcomes, such as the need for dialysis or neu- Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc
rologic injury, were investigated to evaluate for potential Surg 2014; 147:658–664
end-organ injury due to hyperoxia. There was no statistical 3. Salvin JW, Laussen PC, Thiagarajan RR: Extracorporeal membrane
oxygenation for postcardiotomy mechanical cardiovascular support
difference in terms of neurologic injury (seizures, intracranial
in children with congenital heart disease. Paediatr Anaesth 2008;
hemorrhage, or strokes). However, only a limited number of 18:1157–1162
patients in the cohort had brain MRI, which is considered to 4. Hayes RA, Shekar K, Fraser JF: Is hyperoxaemia helping or hurting
be the standard evaluation of white-matter brain injury. Future patients during extracorporeal membrane oxygenation? Review of a
complex problem. Perfusion 2013; 28:184–193
studies would be helpful to further evaluate brain matter
5. Del Castillo J, López-Herce J, Matamoros M, et al; Iberoamerican
injury and neurodevelopmental outcomes of patients exposed Pediatric Cardiac Arrest Study Network RIBEPCI: Hyperoxia, hypo-
to hyperoxia while on ECMO. capnia and hypercapnia as outcome factors after cardiac arrest in
children. Resuscitation 2012; 83:1456–1461
The data did suggest that there was an increased risk for
6. Ferguson LP, Durward A, Tibby SM: Relationship between arterial
the need for renal replacement therapy in those patients with
partial oxygen pressure after resuscitation from cardiac arrest and
a mean Pao greater than 193 mm Hg. Previous studies have mortality in children. Circulation 2012; 126:335–342
2
also indicated that renal failure is a risk factor for death while 7. Guerra-Wallace MM, Casey FL 3rd, Bell MJ, et al: Hyperoxia and
on ECMO (18). As discussed above, it is possible that the need hypoxia in children resuscitated from cardiac arrest. Pediatr Crit Care
Med 2013; 14:e143–e148
for dialysis could be due to the negative effects of hyperoxia
8. Janz DR, Hollenbeck RD, Pollock JS, et al: Hyperoxia is associ-
with generation of reactive oxygen species leading to worsen- ated with increased mortality in patients treated with mild therapeu-
ing renal failure. However, it is also possible that the need for tic hypothermia after sudden cardiac arrest. Crit Care Med 2012;
40:3135–3139
dialysis was simply a marker of a more critically ill patient with
9. Kilgannon JH, Jones AE, Parrillo JE, et al; Emergency Medicine
worse ventricular function and the need for higher ECMO
Shock Research Network (EMShockNet) Investigators: Relationship
pump flows although these variables were not seen as indepen- between supranormal oxygen tension and outcome after resuscitation
dent risk factors. from cardiac arrest. Circulation 2011; 123:2717–2722
Limitations of this study include the fact that it was a ret- 10. Vaahersalo J, Bendel S, Reinikainen M, et al; FINNRESUSCI Study
Group: Arterial blood gas tensions after resuscitation from out-of-hos-
rospective chart review performed at a single center and that
pital cardiac arrest: Associations with long-term neurologic outcome.
there may have been other important clinical variables that Crit Care Med 2014; 42:1463–1470
could not be measured in a retrospective manner. Specifically, 11. Klinger G, Beyene J, Shah P, et al: Do hyperoxaemia and hypocapnia
add to the risk of brain injury after intrapartum asphyxia? Arch Dis
data were not available or collected with regard to the total
Child Fetal Neonatal Ed 2005; 90:F49–F52
oxygen delivery such as specific ventilator settings and the
12. Rabi Y, Rabi D, Yee W: Room air resuscitation of the depressed new-
variation in hemoglobin of each patient. In addition, variation born: A systematic review and meta-analysis. Resuscitation 2007;
among individual intensivists with regard to clinical practice 72:353–363
of patients on ECMO may have contributed to confounding 13. Stub D, Smith K, Bernard S, et al; AVOID Study: A randomized con-
trolled trial of oxygen therapy in acute myocardial infarction Air Verses
data. Finally, due to the retrospective nature of the data collec-
Oxygen In myocarDial infarction study (AVOID Study). Am Heart J
tion, advanced data analysis using longitudinal mixed model- 2012; 163:339–345.e1
ing to further define the relationship between Pao values and 14. Caputo M, Mokhtari A, Miceli A, et al: Controlled reoxygenation during
2 cardiopulmonary bypass decreases markers of organ damage, inflam-
outcomes could not be performed.
mation, and oxidative stress in single-ventricle patients undergoing pedi-
atric heart surgery. J Thorac Cardiovasc Surg 2014; 148:792–801.e8
CONCLuSIONS 15. Caputo M, Mokhtari A, Rogers CA, et al: The effects of normoxic
versus hyperoxic cardiopulmonary bypass on oxidative stress and
In the postoperative period, a mean Pao greater than 193 mm inflammatory response in cyanotic pediatric patients undergoing open
2
Hg while on ECMO was an independent risk factor for mor- cardiac surgery: A randomized controlled trial. J Thorac Cardiovasc
Surg 2009; 138:206–214
tality in infants with congenital heart disease. The results of
16. Jacobs JP, Jacobs ML, Maruszewski B, et al: Initial application
the study indicate that not only are future prospective stud-
in the EACTS and STS Congenital Heart Surgery Databases of
ies necessary to investigate the effect of hyperoxia while on an empirically derived methodology of complexity adjustment to
Pediatric Critical Care Medicine www.pccmjournal.org 357
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited
Sznycer-Taub et al
evaluate surgical case mix and results. Eur J Cardiothorac Surg 24. Yeh ST, Aune SE, Wilgus TA, et al: Hyperoxemic reperfusion after pro-
2012; 42:775–779 longed cardiac arrest in a rat cardiopulmonary bypass resuscitation
17. Brix-Christensen V: The systemic inflammatory response after cardiac model. Resuscitation 2013; 84:114–120
surgery with cardiopulmonary bypass in children. Acta Anaesthesiol 25. Miyamoto O, Auer RN: Hypoxia, hyperoxia, ischemia, and brain necro-
Scand 2001; 45:671–679 sis. Neurology 2000; 54:362–371
18. Alsoufi B, Al-Radi OO, Gruenwald C, et al: Extra-corporeal life sup- 26. Trabattoni D, Bartorelli AL, Fabbiocchi F, et al: Hyperoxemic perfu-
port following cardiac surgery in children: Analysis of risk factors sion of the left anterior descending coronary artery after primary
and survival in a single institution. Eur J Cardiothorac Surg 2009; angioplasty in anterior ST-elevation myocardial infarction. Catheter
35:1004–1011 Cardiovasc Interv 2006; 67:859–865
19. Chrysostomou C, Morell VO, Kuch BA, et al: Short- and interme- 27. O’Neill WW, Martin JL, Dixon SR, et al; AMIHOT Investigators: Acute
diate-term survival after extracorporeal membrane oxygenation in Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): A prospec-
children with cardiac disease. J Thorac Cardiovasc Surg 2013; tive, randomized trial of intracoronary hyperoxemic reperfusion after per-
146:317–325 cutaneous coronary intervention. J Am Coll Cardiol 2007; 50:397–405
20. Turer AT, Hill JA: Pathogenesis of myocardial ischemia-reperfusion 28. Kleinman ME, de Caen AR, Chameides L, et al; Pediatric Basic and
injury and rationale for therapy. Am J Cardiol 2010; 106:360–368 Advanced Life Support Chapter Collaborators: Part 10: Pediatric
21. Lefer DJ, Granger DN: Oxidative stress and cardiac disease. Am J basic and advanced life support: 2010 International Consensus
Med 2000; 109:315–323 on Cardiopulmonary Resuscitation and Emergency Cardiovascular
22. Saugstad OD: Oxidative stress in the newborn–a 30-year perspec- Care Science With Treatment Recommendations. Circulation 2010;
tive. Biol Neonate 2005; 88:228–236 122:S466–S515
23. Elmer J, Scutella M, Pullalarevu R, et al; Pittsburgh Post-Cardiac 29. Peberdy MA, Callaway CW, Neumar RW, et al; American Heart
Arrest Service (PCAS): The association between hyperoxia and Association: Part 9: Post-cardiac arrest care: 2010 American Heart
patient outcomes after cardiac arrest: Analysis of a high-resolution Association Guidelines for Cardiopulmonary Resuscitation and
database. Intensive Care Med 2015; 41:49–57 Emergency Cardiovascular Care. Circulation 2010; 122:S768–S786
358 www.pccmjournal.org April 2016 • Volume 17 • Number 4
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited
